We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Consumer Discretionary 10.36%
3 Financials 6.9%
4 Industrials 6.78%
5 Healthcare 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCYX icon
2076
SCYNEXIS
SCYX
$52.1M
$140K ﹤0.01%
2,375
+200
+9% +$12.6K
LFCR icon
2077
Lifecore Biomedical
LFCR
$182M
$139K ﹤0.01%
+12,369
New +$143K
NSLR
2078
Neostellar Capital Corp
NSLR
$251M
$137K ﹤0.01%
+10,158
New +$132K
INFI
2079
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$136K ﹤0.01%
45,525
-140,961
-76% -$446K
AKUS
2080
DELISTED
Akouos Inc
AKUS
$136K ﹤0.01%
+10,800
New +$146K
GALT icon
2081
Galectin Therapeutics
GALT
$320M
$135K ﹤0.01%
+42,042
New +$150K
LFVN icon
2082
LifeVantage
LFVN
$83.1M
$135K ﹤0.01%
+18,397
New +$150K
SVRA icon
2083
Savara
SVRA
$1.19B
$135K ﹤0.01%
79,144
+57,550
+267% +$104K
CAN
2084
Canaan Creative
CAN
$155M
$134K ﹤0.01%
+16,410
New +$186K
NXE icon
2085
NexGen Energy
NXE
$6.91B
$134K ﹤0.01%
+32,636
New +$139K
AXLA
2086
DELISTED
Axcella Health Inc. Common Stock
AXLA
$134K ﹤0.01%
+1,337
New +$133K
EVFM
2087
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$134K ﹤0.01%
7,892
+6,889
+687% +$131K
CRBP icon
2088
Corbus Pharmaceuticals
CRBP
$183M
$133K ﹤0.01%
2,420
+1,153
+91% +$64K
QTTB icon
2089
Q32 Bio
QTTB
$474M
$132K ﹤0.01%
+1,008
New +$126K
EGIO
2090
DELISTED
Edgio, Inc. Common Stock
EGIO
$131K ﹤0.01%
+1,042
New +$138K
KLR
2091
DELISTED
Kaleyra, Inc.
KLR
$131K ﹤0.01%
3,057
-514
-14% -$23.2K
CMO
2092
DELISTED
Capstead Mortgage Corp.
CMO
$131K ﹤0.01%
+21,263
New +$137K
ADVM
2093
DELISTED
Adverum Biotechnologies
ADVM
$130K ﹤0.01%
+3,706
New +$200K
POWW icon
2094
Outdoor Holding Co
POWW
$288M
$130K ﹤0.01%
+13,327
New +$94.7K
XHE icon
2095
State Street SPDR S&P Health Care Equipment ETF
XHE
$167M
$130K ﹤0.01%
+1,004
New +$123K
AGEN
2096
Agenus
AGEN
$286M
$129K ﹤0.01%
+1,197
New +$89.8K
BF.A icon
2097
Brown-Forman Class A
BF.A
$13.1B
$127K ﹤0.01%
1,807
+1,138
+170% +$81.1K
KEP icon
2098
Korea Electric Power
KEP
$15.9B
$127K ﹤0.01%
+11,800
New +$130K
NAGE
2099
Niagen Bioscience
NAGE
$241M
$126K ﹤0.01%
12,792
-19,977
-61% -$174K
AREC icon
2100
American Resources Corp
AREC
$298M
$125K ﹤0.01%
49,102
-898
-2% -$2.71K
82 83
84
85 86

Similar funds

LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

ExodusPoint Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, ExodusPoint Capital Management held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

ExodusPoint Capital Management deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • ExodusPoint Capital Management's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • ExodusPoint Capital Management added most to Microsoft in Q2 2021, an estimated $435M increase.
  • ExodusPoint Capital Management's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • ExodusPoint Capital Management fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • ExodusPoint Capital Management's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • ExodusPoint Capital Management opened 1,032 new positions and closed 820 in Q2 2021.
  • ExodusPoint Capital Management's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.